Han-Jung Tsai

Title: The Innovations of Han-Jung Tsai

Introduction

Han-Jung Tsai is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of pharmaceutical compounds. His work focuses on innovative solutions for treating serious health conditions, including cancer.

Latest Patents

Han-Jung Tsai holds a patent for a compound known as .alpha.-methylene peperomins and halogenated derivatives thereof. This compound is characterized by a specific formula that includes various substituents, which can represent hydrogen, hydroxy, or lower alkoxy groups. The patent also describes a pharmaceutical composition that contains an effective amount of this compound, along with a pharmaceutically acceptable excipient. Furthermore, it outlines a method for treating cancer through the administration of this compound to patients in need.

Career Highlights

Han-Jung Tsai is associated with the Development Center for Biotechnology, where he has been instrumental in advancing research and development in the field. His innovative approach and dedication to biotechnology have positioned him as a key figure in his organization.

Collaborations

He has collaborated with notable coworkers, including Shan-Yen Chou and Shan-Shue Wang, contributing to various projects that aim to enhance the efficacy of pharmaceutical treatments.

Conclusion

Han-Jung Tsai's work exemplifies the spirit of innovation in biotechnology. His patent and contributions to cancer treatment reflect his commitment to improving health outcomes through scientific advancements.